Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 469 (ZNF469)
- Target
- ZNF469
- Molecular classification
- Transcription factor (C2H2 zinc finger protein), Other (Extracellular matrix regulator protein)
01
Overview
Zinc finger protein 469 (ZNF469) is a very large C2H2-type zinc finger transcription factor mainly implicated in the transcriptional regulation of genes encoding extracellular matrix components, particularly collagens and proteoglycans. Its physiological role is most critical in the cornea, where it maintains proper tissue architecture and thickness. Loss-of-function mutations lead to extreme corneal thinning and fragility, as seen in brittle cornea syndrome (BCS1), and confer increased risk for keratoconus. There is currently no direct pharmacological intervention targeting ZNF469, and its protein product lacks well-characterized functional domains outside its zinc finger regions.
- Other names
- ZNF469zinc finger protein 469BCSBCS1Zfp469KIAA1858
02
Mechanism of action
No defined mechanisms for drugs targeting this molecule, as there are currently no such drugs.
03
Biological functions
Transcriptional regulationRegulation of extracellular matrix synthesis and degradation (collagens, proteoglycans)Maintenance of corneal structure and thickness
04
Disease associations
Brittle cornea syndrome (BCS1)KeratoconusType of Ehlers-Danlos syndrome ("brittle cornea syndrome")
05
Safety considerations
Therapeutic challenges due to lack of druggable domains and unknown functionRisk of corneal rupture and severe ocular complications in affected individuals, but not specific to therapy
06
Biomarkers
ZNF469 gene mutations (for patient selection/diagnosis of BCS and risk stratification for keratoconus)Central corneal thickness as a clinical phenotype linked to ZNF469 variants
Beyond the preview
Go deeper on Zinc finger protein 469 (ZNF469).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zinc finger protein 469 (ZNF469).